These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33664990)

  • 1. Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells.
    Yang D; Feng W; Zhuang Y; Liu J; Feng Z; Xu T; Wang W; Zhu Y; Wang Z
    Mol Ther Nucleic Acids; 2021 Mar; 23():1053-1065. PubMed ID: 33664990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC.
    Liu X; Lu X; Zhen F; Jin S; Yu T; Zhu Q; Wang W; Xu K; Yao J; Guo R
    Mol Ther Nucleic Acids; 2019 Jun; 16():155-161. PubMed ID: 30889481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
    Wang L; Shang X; Feng Q
    Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
    Xiao XH; He SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA GAS5 accelerates oxidative stress in melanoma cells by rescuing EZH2-mediated CDKN1C downregulation.
    Xu W; Yan Z; Hu F; Wei W; Yang C; Sun Z
    Cancer Cell Int; 2020; 20():116. PubMed ID: 32308561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
    Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
    Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer.
    Jia D; Xing Y; Zhan Y; Cao M; Tian F; Fan W; Huang J; Cui Y; Gu R; Cui Y; Liu Y; Zhang S; Cai L; Li X
    Front Cell Dev Biol; 2021; 9():686975. PubMed ID: 34124072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
    Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
    Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1.
    Xue P; Yan M; Wang K; Gu J; Zhong B; Tu C
    Front Oncol; 2021; 11():639060. PubMed ID: 34094920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase 1 as a target is regulated by the hsa-let-7b-5p/LINC00665 axis and affects NSCLC prognosis.
    Zhu XD; Fan YF; Zhao Y; Song XY; Liu XS; Gao ZJ; Yuan K
    Heliyon; 2023 Nov; 9(11):e21328. PubMed ID: 37954276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
    Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
    Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
    EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.
    Zhou JL; Zou L; Zhu T
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3097-3104. PubMed ID: 32271427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Roles of LINC00665 in Human Cancers.
    Zhu J; Zhang Y; Chen X; Bian Y; Li J; Wang K
    Front Cell Dev Biol; 2022; 10():839177. PubMed ID: 35356290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation
    Zhang C; Kang T; Wang X; Wang J; Liu L; Zhang J; Liu X; Li R; Wang J; Zhang J
    Front Pharmacol; 2022; 13():968223. PubMed ID: 36091809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.